Enlivex ENLV
NASDAQ ENLV
$1.47 -0.03 (-2.00%)
At close: Aug 21, 2026 · 4:00 PM EDT

Enlivex (ENLV) Other Operating Expenses (2015 - 2025)

Enlivex (ENLV) posted quarterly Other Operating Expenses of $1.3 billion for Q4 2025, up 142418.18% year-over-year from N/an in Q4 2024, and up 18114971.43% quarter-over-quarter from $7000.0 in Q2 2025.

Enlivex (ENLV) Other Operating Expenses (2015 - 2025) Analysis & Trends

Enlivex's Other Operating Expenses history runs 8 years deep, the most recent figure standing at $1.3 billion for Q4 2025.

  • In Q4 2025, Other Operating Expenses rose 142418.18% year-over-year to $1.3 billion; the TTM figure through Dec 2025 stood at $1.3 billion (up 183881.3% YoY), while the FY2025 annual figure was $1.3 billion, up 132606.17% from the prior year.
  • Other Operating Expenses for Q4 2025 stood at $1.3 billion, up from $7000.0 in the prior quarter.
  • The five-year high for Other Operating Expenses was $1.3 billion in Q4 2025, with the low at -$891000.0 in Q4 2024.
  • The 5-year median for Other Operating Expenses is $115000.0 (2024), against an average of $127.2 million.
  • The sharpest annual moves came in 2024 and 2025: Other Operating Expenses plunged 120.99% in 2024, then soared 142418.18% in 2025.
  • Enlivex's Other Operating Expenses stood at $440000.0 in 2021, then slumped by 112.73% to -$56000.0 in 2022, then jumped by 7678.57% to $4.2 million in 2023, then plunged by 120.99% to -$891000.0 in 2024, then jumped by 142418.18% to $1.3 billion in 2025.
  • Business Quant data shows ENLV's Other Operating Expenses at $1.3 billion in Q4 2025, $7000.0 in Q2 2025, and $29000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Enlivex 4.51 Mn -1.25 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 1.27 Bn
Jun 30, 2025 7,000.00
Mar 31, 2025 29,000.00
Dec 31, 2024 -891,000.00
Sep 30, 2024 -267,000.00
Jun 30, 2024 267,000.00
Mar 31, 2024 201,000.00
Dec 31, 2023 4.24 Mn
Sep 30, 2022 -56,000.00
Sep 30, 2021 440,000.00
Jun 30, 2017 65,000.00
Mar 31, 2017 406,000.00
Dec 31, 2016 875,000.00
Sep 30, 2016 39,000.00
Jun 30, 2016 64,000.00
Mar 31, 2016 772,000.00
Dec 31, 2015 563,000.00
Sep 30, 2015 266,000.00